Cipla (Large Cap) Share Target 2026, 2027 To 2035
|
Cipla Limited |
|||
|
Price: ₹1,389.40 (0.44%) | ||
| 52 Week Low: ₹1,165.70 52 Week High: ₹1,673.00 |
|||
| Market Capital: 1,05,577.18 Crore (Large-cap) | |||
| Healthcare -> Drug Manufacturers—General | |||
Share Price HistoryCIPLA FinancialsTomorrow TargetYearly TargetsDividend HistoryBonus HistorySplit History
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Cipla Share Price Target For 2026
- 1.1.1: Cipla Share Price Target Table For 2026
- 1.1.2: Short-Term Technical Outlook
- 1.2: Cipla Share Price Target For 2027
- 1.2.1: Cipla Share Price Target Table For 2027
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Cipla Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
- 3: Cipla Brief Company Overview
- 4: Cipla Financial Performance
- 4.0.1: Is Cipla A Good Buy For Long Term?
Cipla, a Large Cap company in the Drug Manufacturers—General Industry has delivered 45.0% returns in 5-year showing 5.6% quarterly revenue growth with 17.0% profit margin.
To predict the Cipla's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Cipla Share Price Target For 2026
The line chart displays the monthly closing prices of Cipla with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Cipla shares in 2026, see the table below.
Cipla Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 1465.05 (+5.44%) | Volatility: ATR T1 |
| 2026 Target 2 | 1432.17 (+3.07%) | Volatility: BB Upper |
| 2026 Target 1 | 1428.63 (+2.82%) | Trend: SMA200 |
| Current Price | 1389.40 | Cipla's share price as of 12 Jun 2026 |
| Stop Loss 1 | 1387.35 (-0.15%) | Trend: EMA9 |
| Stop Loss 2 | 1366.00 (-1.69%) | Volatility: BB Lower |
| Stop Loss 3 | 1324.61 (-4.67%) | Trend: SMA50 |
Short-Term Technical Outlook
Current Technical Position: Cipla is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 50-day moving average at ₹1324.61 serves as the nearest technical reference point.
Historical Returns: 3-month: +4.86% | 6-month: -8.48% | 1-year: -6.69%
Cipla Share Price Target For 2027
The line chart displays the monthly closing prices of Cipla with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Cipla shares in 2027, see the table below.
Cipla Share Price Target Table For 2027
| Level | Value | Analysis |
|---|---|---|
| 2027 Target 3 | 1465.05 (+5.44%) | Volatility: ATR T1 |
| 2027 Target 2 | 1432.17 (+3.07%) | Volatility: BB Upper |
| 2027 Target 1 | 1428.63 (+2.82%) | Trend: SMA200 |
| Current Price | 1389.40 | Cipla's share price as of 12 Jun 2026 |
| Stop Loss 1 | 1387.35 (-0.15%) | Trend: EMA9 |
| Stop Loss 2 | 1366.00 (-1.69%) | Volatility: BB Lower |
| Stop Loss 3 | 1324.61 (-4.67%) | Trend: SMA50 |
Long-Term Technical Outlook
52-Week Range Analysis: Cipla is currently trading at 44.1% of its 52-week range (₹1165.7 - ₹1673).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -6.69% | 3-year: +44.8% | 5-year: +45.01%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Cipla Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,389.40 | ||
| 2026 | ₹1,544.04 | +11.129984165827% | ₹1,567.20 |
| 2027 | ₹1,907.59 | +23.545374472164% | ₹1,936.20 |
| 2028 | ₹2,221.66 | +16.464229734901% | ₹2,254.98 |
| 2029 | ₹2,702.11 | +21.625721307491% | ₹2,742.64 |
| 2030 | ₹3,486.76 | +29.038418125095% | ₹3,539.06 |
| 2031 | ₹4,087.04 | +17.21598274616% | ₹4,148.35 |
| 2032 | ₹4,683.97 | +14.60543571876% | ₹4,754.23 |
| 2033 | ₹5,554.44 | +18.584021673922% | ₹5,637.76 |
| 2034 | ₹6,597.65 | +18.781551335508% | ₹6,696.61 |
| 2035 | ₹7,152.87 | +8.4154206421984% | ₹7,260.16 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Cipla Brief Company Overview
Company Overview: Cipla Limited Cipla Limited is a renowned pharmaceutical manufacturer operating globally, including India, the US, and South Africa. Established in 1935, the company has a rich history of innovation and is known for its commitment to healthcare. Key...
Products and Services: Pharmaceutical products, including active pharmaceutical ingredients and formulations Therapeutic areas: cardiovascular, diabetes, HIV, respiratory, oncology, and more Respiratory products, including inhalers and nasal sprays Other products: injectables, biosimilars, liquid paraffin for constipation Reputation: Cipla Limited holds a strong reputation in the pharmaceutical industry. The company is committed to providing high-quality, affordable medicines to its customers.Cipla Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,21,591.49 Crore | Market valuation of Cipla's shares. |
| Revenue (TTM) | 26,264.18 Crore | Total revenue generated by Cipla over the past twelve months. |
| Net Income (TTM) | +4,475.11 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 23.18% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 17.03% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+5.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+15.2% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
1.62 | Company's total debt divided by total shareholder equity. |
| Total Debt | 461.37 Crore | Sum of Cipla's current & long-term financial obligations. |
| Total Cash | 8,708.2 Crore | Total amount of liquid funds available to Cipla. |
| Beta | 0.34 | Beta is less than 1 indicating that the Cipla's price is less volatile than the market. |
Is Cipla A Good Buy For Long Term?
Cipla, a large-cap stock with a market capitalization of ₹1,21,591.49 crore, shows strong financial health. Its ₹4,475.11 crore net profit (17.03% margin) on ₹26,264.18 crore revenue in the last 12 months, coupled with a healthy cash balance of ₹8,708.2 crore and relatively low debt (₹461.37 crore as of Q2 2024-25), paints a positive picture. While recent quarterly growth is moderate (5.6% revenue increase), the impressive 5-year return of 186.60% suggests strong long-term potential. Overall, Cipla is a good buy for long-term investors.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
